Dr. Krishe Menezes, MD

Dr. Menezes practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Menezes' NPI, 1568639573, was assigned on May 9, 2008. Dr. Menezes graduated from Goa Medical College in 1994. Dr. Menezes holds California license C150040.

Dr. Menezes' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Menezes' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Menezes is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Menezes to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menezes practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Menezes' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Menezes is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Menezes' licenses on file in 2 states: California and Ohio.

Dmand AI lists essential tremor, muscle disease and parkinson's disease among the conditions Dr. Menezes treats.

CMS data shows 12,125 Medicare services from Dr. Menezes across 11 procedure codes in 2024, for 215 Medicare patients. Medicare paid $119,834 for them.

CMS counts 215 Medicare patients who saw Dr. Menezes in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Menezes' median patient age at 71, with 48% women.

In 2024, Dr. Menezes wrote 927 Medicare Part D claims for 145 patients. 84% of them were for generic drugs. CMS names the drug for 865 of them, across 22 drugs with 11 or more claims each, at $730,504 in total drug cost. In 2023, CMS named 764 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Menezes for performance year 2024, reported as part of a group. Dr. Menezes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menezes as offering telehealth.

Dmand AI links 4 papers to Dr. Menezes, published from 2011 to 2019. Dr. Menezes' most frequent co-authors are Raza Mian, MD, Ogochukwu Chidozie Molokwu, MD and Manjit Singh, MD.

CMS Open Payments shows 65 general payments to Dr. Menezes from 13 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 54% of the total. Medtronic, Inc. paid the most, $1,449.

Dmand AI lists 8 awards for Dr. Menezes, most recently America's top physicians in 2013.

Dr. Menezes graduated from Goa Medical College in 1994. Dr. Menezes is a member of AAN and MDS.

Dr. Menezes is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.